In addition, studies on Burkitt lymphoma (EB1) cell lines and diffuse large B-cell lymphoma (SU-DHL-6) cell lines found that siRNA-mediated inhibition of BCL11A expression reduced cell viability and directed cells toward apoptosis [15]. This evidence concerns the gene BCL11A and diffuse large B-cell lymphoma.